Clinical Trial Update: High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating high-dose ruxolitinib with allogeneic stem cell transplantation for patients with myelofibrosis and splenomegaly is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis
• Splenomegaly

Drugs mentioned

• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Splenomegaly, Myelofibrosis | Phase 2 | Status: RECRUITING